Deficiency of Biogenic Amines Modulates the Activity of Hypoglossal Nerve in the Reserpine Model of Parkinson's Disease

Cells. 2021 Mar 2;10(3):531. doi: 10.3390/cells10030531.

Abstract

The underlying cause of respiratory impairments appearing in Parkinson's disease (PD) is still far from being elucidated. To better understand the pathogenesis of respiratory disorders appearing in PD, we studied hypoglossal (HG) and phrenic (PHR) motoneuron dysfunction in a rat model evoked with reserpine administration. After reserpine, a decrease in the baseline amplitude and minute HG activity was noted, and no depressive phase of the hypoxic ventilatory response was observed. The pre-inspiratory time of HG activity along with the ratio of pre-inspiratory time to total respiratory cycle time and the ratio of pre-inspiratory to inspiratory amplitude were significantly reduced during normoxia, hypoxia, and recovery compared to sham rats. We suggest that the massive depletion of not only dopamine, but above all noradrenaline and serotonin in the brainstem observed in our study, has an impact on the pre-inspiratory activity of the HG. The shortening of the pre-inspiratory activity of the HG in the reserpine model may indicate a serious problem with maintaining the correct diameter of the upper airways in the preparation phase for inspiratory effort and explain the development of obstructive sleep apnea in some PD patients. Therapies involving the supplementation of amine depletion other than dopamine should be considered.

Keywords: Parkinson’s diseases; biogenic amines; hypoglossal nerve; hypoxia; phrenic nerve; reserpine model.

MeSH terms

  • Animals
  • Biogenic Amines / metabolism*
  • Disease Models, Animal
  • Humans
  • Hypoglossal Nerve / drug effects*
  • Male
  • Parkinson Disease / physiopathology*
  • Rats
  • Rats, Wistar
  • Reserpine / pharmacology
  • Reserpine / therapeutic use*

Substances

  • Biogenic Amines
  • Reserpine